Stephanie Fuller

4.3k total citations · 1 hit paper
29 papers, 3.3k citations indexed

About

Stephanie Fuller is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stephanie Fuller has authored 29 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stephanie Fuller's work include Alzheimer's disease research and treatments (13 papers), Congenital Heart Disease Studies (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Stephanie Fuller is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Congenital Heart Disease Studies (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Stephanie Fuller collaborates with scholars based in Australia, Germany and United States. Stephanie Fuller's co-authors include Colin L. Masters, Ashley I. Bush, Margaret J. Smith, Catriona McLean, Fiona Fraser, Robert A. Cherny, Ralph N. Martins, Giuseppe Verdile, Robert D. Moir and Elizabeth A. Milward and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Neuron.

In The Last Decade

Stephanie Fuller

26 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1999 1.5k citations Catriona McLean, Robert A. Cherny et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Fuller Australia	19	2.4k	1.3k	652	626	409	29	3.3k
Lorenzo M. Refolo United States	23	2.3k 1.0×	1.2k 0.9×	471 0.7×	486 0.8×	350 0.9×	41	3.4k
Yoshie Takaki Japan	14	2.1k 0.9×	1.1k 0.8×	879 1.3×	649 1.0×	410 1.0×	17	3.0k
Karin Axelman Sweden	18	2.4k 1.0×	1.5k 1.1×	458 0.7×	530 0.8×	306 0.7×	33	2.9k
Laura Gasparini Italy	32	2.1k 0.9×	1.7k 1.3×	720 1.1×	551 0.9×	597 1.5×	66	3.9k
Wesley Farris United States	10	1.9k 0.8×	987 0.7×	416 0.6×	485 0.8×	414 1.0×	11	2.7k
Roberta Borghi Italy	25	2.0k 0.8×	1.2k 0.9×	468 0.7×	606 1.0×	407 1.0×	49	3.2k
Arlene M. Manelli United States	20	2.2k 0.9×	1.4k 1.0×	666 1.0×	499 0.8×	478 1.2×	29	3.0k
Bruno Vincent France	33	2.1k 0.9×	2.1k 1.6×	994 1.5×	573 0.9×	614 1.5×	70	4.2k
John J. LaFrancois United States	24	2.6k 1.1×	1.4k 1.1×	1.4k 2.1×	523 0.8×	608 1.5×	36	4.5k

Countries citing papers authored by Stephanie Fuller

Since Specialization

Citations

This map shows the geographic impact of Stephanie Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Fuller more than expected).

Fields of papers citing papers by Stephanie Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Fuller. The network helps show where Stephanie Fuller may publish in the future.

Co-authorship network of co-authors of Stephanie Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Fuller. A scholar is included among the top collaborators of Stephanie Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Fuller. Stephanie Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sutherland, B. J., et al.. (2025). Open atrial septal defect repair in a dog using fresh autologous pericardium. Journal of Veterinary Cardiology. 60. 30–35.

Blitzer, David, Lin Chen, Alvise Guariento, et al.. (2023). The Impact of Congenital Cardiac Surgery Fellowship on Training and Practice. The Annals of Thoracic Surgery. 116(6). 1320–1327. 2 indexed citations

Chen, Juliana, Stephanie Fuller, Belinda M. Brown, et al.. (2023). Baseline diet quality of participants in AU‐ARROW trial based on adherence to the MIND diet recommendations. Alzheimer s & Dementia. 19(S23).

Patel, Bhavesh, Lauren Andrade, Stephanie Fuller, et al.. (2020). LYMPHOPENIA IN ADULT PATIENTS WITH FONTAN PHYSIOLOGY. Journal of the American College of Cardiology. 75(11). 610–610.

Patel, Bhavesh, Joyce Wald, Srinivas Denduluri, et al.. (2019). Abstract 14367: Diuretic Use is Associated With Worse Transplant-Free Survival in Adult Fontan Patients. Circulation. 1 indexed citations

Wahjoepramono, Eka Julianta, Prita R. Asih, Kevin Taddei, et al.. (2016). The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men.. CNS & Neurological Disorders - Drug Targets. 15(3). 337–343. 50 indexed citations

Asih, Prita R., Eka Julianta Wahjoepramono, Karl De Ruyck, et al.. (2015). Testosterone Replacement Therapy in Older Male Subjective Memory Complainers: Double-Blind Randomized Crossover Placebo-Controlled Clinical Trial of Physiological Assessment and Safety. CNS & Neurological Disorders - Drug Targets. 14(5). 576–586. 18 indexed citations

Verdile, Giuseppe, Stephanie Fuller, & Ralph N. Martins. (2015). The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease. 84. 22–38. 207 indexed citations

Martins, Ian, Andrea C. Wilson, Wei Ling Florence Lim, et al.. (2012). Sirtuin-1 mediates the obesity induced risk of common degenerative diseases: Alzheimer’s disease, coronary artery disease and type 2 diabetes. Australasian Journal of Paramedicine. 4(12). 1448–1456. 11 indexed citations

10.

Albiston, Anthony L., Holly R. Yeatman, Vi Pham, et al.. (2010). Distinct distribution of GLUT4 and insulin regulated aminopeptidase in the mouse kidney. Regulatory Peptides. 166(1-3). 83–89. 25 indexed citations

11.

Martins, Ian, Tamar Berger, Matthew J. Sharman, et al.. (2009). Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease. Journal of Neurochemistry. 111(6). 1275–1308. 184 indexed citations

12.

Gunnersen, Jenny M., Stephanie Fuller, Melanie de Silva, et al.. (2007). Sez-6 Proteins Affect Dendritic Arborization Patterns and Excitability of Cortical Pyramidal Neurons. Neuron. 56(4). 621–639. 104 indexed citations

13.

Fuller, Stephanie, et al.. (2003). ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease. Annals of Human Biology. 30(6). 639–667. 36 indexed citations

14.

Fuller, Stephanie, et al.. (2002). Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. American Journal of Hematology. 72(1). 31–33. 14 indexed citations

15.

McLean, Catriona, Robert A. Cherny, Fiona Fraser, et al.. (1999). Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Annals of Neurology. 46(6). 860–866. 1506 indexed citations breakdown →

16.

Culvenor, Janetta G., et al.. (1995). Expression of the Amyloid Precursor Protein of Alzheimer's Disease on the Surface of Transfected HeLa Cells. Experimental Cell Research. 220(2). 474–481. 10 indexed citations

17.

Milward, Elizabeth A., Roula Papadopoulos, Stephanie Fuller, et al.. (1992). The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9(1). 129–137. 388 indexed citations

18.

Small, David H., Robert D. Moir, Stephanie Fuller, et al.. (1991). A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease. Biochemistry. 30(44). 10795–10799. 76 indexed citations

19.

Bush, Ashley I., Ralph N. Martins, B. Rumble, et al.. (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets.. Journal of Biological Chemistry. 265(26). 15977–15983. 270 indexed citations

20.

Vassy, Jany, et al.. (1986). The effect of dexamethasone on transferrin secretion by cultured fetal rat hepatocytes.. PubMed. 42(1). 52–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact